These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 598949

  • 1. The effect of oral spironolactone and intravenous canrenoate-K on the digoxin radioimmunoassay.
    Lichey J, Schröder R, Rietbrock N.
    Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):557-9. PubMed ID: 598949
    [Abstract] [Full Text] [Related]

  • 2. Plasma digoxin radioimmunoassay in patients treated with potassium canrenoate and spironolactone. A comparison of two commerical kits.
    Cristodorescu R, Gavrilescu S, Deutsch G, Berger E.
    Agressologie; 1978 Dec; 19(6):409-14. PubMed ID: 751526
    [No Abstract] [Full Text] [Related]

  • 3. Effect of spironolactone, potassium canrenoate and their common metabolite canrenone on serum digoxin measurement by digoxin III, a new digoxin immunoassay.
    Dasgupta A, Tso G, Wells A.
    Ther Drug Monit; 2008 Dec; 30(6):744-7. PubMed ID: 18824952
    [Abstract] [Full Text] [Related]

  • 4. [Plasma-digoxin concentration in patients at time of hospital admission (author's transl)].
    Lichey J, Schröder R, Rietbrock N.
    Dtsch Med Wochenschr; 1977 Jul 22; 102(29):1056-60. PubMed ID: 891379
    [Abstract] [Full Text] [Related]

  • 5. The influence of intravenous canrenoate on the determination of digoxin in serum by radio- and enzyme-immunoassay.
    Lichey J, Rietbrock N, Borner K.
    Int J Clin Pharmacol Biopharm; 1979 Feb 22; 17(2):61-3. PubMed ID: 370036
    [No Abstract] [Full Text] [Related]

  • 6. Abbott ARCHITECT clinical chemistry and immunoassay systems: digoxin assays are free of interferences from spironolactone, potassium canrenoate, and their common metabolite canrenone.
    DeFrance A, Armbruster D, Petty D, Cooper KC, Dasgupta A.
    Ther Drug Monit; 2011 Feb 22; 33(1):128-31. PubMed ID: 21079546
    [Abstract] [Full Text] [Related]

  • 7. Spironolactone interference with digoxin radioimmunoassay in cirrhotic patients.
    DiPiro JT, Cote JR, DiPiro CR, Bustrack JA.
    Am J Hosp Pharm; 1980 Nov 22; 37(11):1518-21. PubMed ID: 7211855
    [Abstract] [Full Text] [Related]

  • 8. The effect of spironolactone and canrenone on the digoxin radioimmunoassay.
    Huffman DH.
    Res Commun Chem Pathol Pharmacol; 1974 Dec 22; 9(4):787-90. PubMed ID: 4477402
    [No Abstract] [Full Text] [Related]

  • 9. Influence of canrenoate-K and cardiac glycosides on their tissue distribution and elimination.
    Kuhlmann J, Kötter V, Vöhringer HF, Rietbrock N, Schröder R.
    Arzneimittelforschung; 1977 Jul 22; 27(7):1505-9. PubMed ID: 578485
    [Abstract] [Full Text] [Related]

  • 10. [Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension].
    Tosti-Croce C, Mantellini R, Fanti P, Sciarra F.
    Minerva Med; 1983 Apr 07; 74(14-15):791-7. PubMed ID: 6339999
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bidirectional (positive/negative) interference of spironolactone, canrenone, and potassium canrenoate on serum digoxin measurement: elimination of interference by measuring free digoxin or using a chemiluminescent assay for digoxin.
    Dasgupta A, Saffer H, Wells A, Datta P.
    J Clin Lab Anal; 2002 Apr 07; 16(4):172-7. PubMed ID: 12112389
    [Abstract] [Full Text] [Related]

  • 13. Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over.
    Emili M, Cuppone R, Ricci GL.
    Arzneimittelforschung; 1988 Oct 07; 38(10):1492-5. PubMed ID: 3058132
    [Abstract] [Full Text] [Related]

  • 14. Clinically insignificant negative interferences of spironolactone, potassium canrenoate, and their common metabolite canrenone in new dimension vista LOCI digoxin immunoassay.
    Dasgupta A, Johnson MJ, Sengupta TK.
    J Clin Lab Anal; 2012 May 07; 26(3):143-7. PubMed ID: 22628228
    [Abstract] [Full Text] [Related]

  • 15. Canrenoate--a spironolactone metabolite. Acute cardiac effects in digitalized patients.
    Waldorff S, Buch J.
    Eur J Cardiol; 1979 Aug 07; 10(2):143-9. PubMed ID: 477703
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Spirolactones: clinical and pharmacologic studies.
    Corvol P, Claire M, Rafestin-Oblin ME, Michaud A, Roth-Meyer C, Menard J.
    Adv Nephrol Necker Hosp; 1977 Aug 07; 7():199-215. PubMed ID: 208407
    [No Abstract] [Full Text] [Related]

  • 18. A new enzyme-linked chemiluminescent immunosorbent digoxin assay is virtually free from interference of spironolactone, potassium canrenoate, and their common metabolite canrenone.
    Dasgupta A, Kang E, Datta P.
    J Clin Lab Anal; 2006 Aug 07; 20(5):204-8. PubMed ID: 16960898
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.